Antonio R. Pera

Board Director

Director

Insider activity · 24 months0 buys2 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 1 saleSept 25 · 0 buys · 1 saleOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (1 ops.)

€112k

▼ Sales (4 ops.)

€1.6M

Latest filing published 10 Jun 2026 for ANI Pharmaceuticals INC. Read the official filing

Filing timeline

BuySale

Antonio R. Pera

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-39.0%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Antonio R. Pera: trading record in brief

Antonio R. Pera is a declared insider of ANI Pharmaceuticals Inc (board member), with filings sourced from SEC (Form 4). The record holds 9 filings, for trades running from 7 December 2021 to 21 May 2026.

Both buying and selling appear: 1 purchase worth €112k, against 4 sales worth €1.6M. Netting one side against the other leaves €1.5M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 4 share grants.

The record was last updated on 10 June 2026 with a share grant in ANI Pharmaceuticals Inc. The last purchase on record was published on 9 December 2021, which is 1,774 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.